Literature DB >> 26168070

Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation.

S Fuji1, K Yakushijin1, S-W Kim1, K Yoshimura2, S Kurosawa1, T Fukuda1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26168070     DOI： 10.1038/bmt.2015.163

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation.

Authors:  J Andersen; C Heilmann; N Jacobsen; C Nielsen; K Bendtzen; K Müller
Journal:  Bone Marrow Transplant       Date:  2006-04       Impact factor: 5.483

3.  Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT.

Authors:  S Fuji; S-W Kim; S Mori; K Furuta; R Tanosaki; Y Heike; Y Takaue; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2009-08-03       Impact factor: 5.483

4.  Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study.

Authors:  Farzad Saberi; Daren Heyland; Miu Lam; Dilys Rapson; Khursheed Jeejeebhoy
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

5.  Insulin sensitivity of glucose and fat metabolism in severe sepsis.

Authors:  C Chambrier; M Laville; M Odeon; P Boulétreau; M Beylot
Journal:  Clin Sci (Lond)       Date:  2000-10       Impact factor: 6.124

Review 6.  Evaluating mechanisms of post-transplant diabetes mellitus.

Authors:  Johannes P van Hooff; Maarten H L Christiaans; Elly M van Duijnhoven
Journal:  Nephrol Dial Transplant       Date:  2004-12       Impact factor: 5.992

7.  Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Sung-Won Kim; Shin-ichiro Mori; Takahiro Fukuda; Shigemi Kamiya; Satoshi Yamasaki; Yuriko Morita-Hoshi; Fusako Ohara-Waki; Osamu Honda; Setsuko Kuwahara; Ryuji Tanosaki; Yuji Heike; Kensei Tobinai; Yoichi Takaue
Journal:  Transplantation       Date:  2007-10-15       Impact factor: 4.939

Review 8.  Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)--a review of recent literature.

Authors:  Corey Scurlock; Jayashree Raikhelkar; Jeffrey I Mechanick
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

9.  Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study.

Authors:  S Fuji; S-W Kim; S Mori; S Kamiya; K Yoshimura; H Yokoyama; S Kurosawa; B Saito; T Takahashi; S Kuwahara; Y Heike; R Tanosaki; Y Takaue; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2009-01-19       Impact factor: 5.483

Review 10.  Bench-to-bedside review: Glucose and stress conditions in the intensive care unit.

Authors:  Marie-Reine Losser; Charles Damoisel; Didier Payen
Journal:  Crit Care       Date:  2010-08-20       Impact factor: 9.097
View more
  2 in total

1.  Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

Authors:  Jenna Sopfe; Laura Pyle; Amy K Keating; Kristen Campbell; Arthur K Liu; R Paul Wadwa; Michael R Verneris; Roger H Giller; Gregory P Forlenza
Journal:  Blood Adv       Date:  2019-02-12

Review 2.  How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

Authors:  S Fuji; A Rovó; K Ohashi; M Griffith; H Einsele; M Kapp; M Mohty; N S Majhail; B G Engelhardt; A Tichelli; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.